Relmada Therapeutics, Inc. (RLMD)

Relmada Therapeutics Statistics

Total Valuation

RLMD has a market cap or net worth of $13.22 million. The enterprise value is -$31.69 million.

Market Cap	13.22M
Enterprise Value	-31.69M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

RLMD has 33.19 million shares outstanding. The number of shares has increased by 0.21% in one year.

Current Share Class	33.19M
Shares Outstanding	33.19M
Shares Change (YoY)	+0.21%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	7.90%
Owned by Institutions (%)	25.21%
Float	28.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.36
P/TBV Ratio	0.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.45

Current Ratio	4.45
Quick Ratio	4.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -132.33% and return on invested capital (ROIC) is -86.75%.

Return on Equity (ROE)	-132.33%
Return on Assets (ROA)	-73.14%
Return on Invested Capital (ROIC)	-86.75%
Return on Capital Employed (ROCE)	-236.14%
Revenue Per Employee	n/a
Profits Per Employee	-$4.70M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.72% in the last 52 weeks. The beta is 0.18, so RLMD's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	-88.72%
50-Day Moving Average	0.33
200-Day Moving Average	1.65
Relative Strength Index (RSI)	52.46
Average Volume (20 Days)	4,420,047

Short Selling Information

The latest short interest is 2.03 million, so 6.13% of the outstanding shares have been sold short.

Short Interest	2.03M
Short Previous Month	1.41M
Short % of Shares Out	6.13%
Short % of Float	7.13%
Short Ratio (days to cover)	0.53

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-83.89M
Pretax Income	-86.76M
Net Income	-79.98M
EBITDA	n/a
EBIT	-83.89M
Earnings Per Share (EPS)	-$2.65

Balance Sheet

The company has $44.91 million in cash and n/a in debt, giving a net cash position of $44.91 million or $1.35 per share.

Cash & Cash Equivalents	44.91M
Total Debt	n/a
Net Cash	44.91M
Net Cash Per Share	$1.35
Equity (Book Value)	35.52M
Book Value Per Share	1.18
Working Capital	35.50M

Cash Flow

Operating Cash Flow	-51.76M
Capital Expenditures	n/a
Free Cash Flow	-51.76M
FCF Per Share	-$1.56

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RLMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.21%
Shareholder Yield	-0.21%
Earnings Yield	-604.98%
FCF Yield	-391.49%

Analyst Forecast

The average price target for RLMD is $4.25, which is 967.04% higher than the current price. The consensus rating is "Hold".

Price Target	$4.25
Price Target Difference	967.04%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-25.92%

Stock Splits

The last stock split was on September 30, 2019. It was a reverse split with a ratio of 0.25:1.

Last Split Date	Sep 30, 2019
Split Type	Reverse
Split Ratio	0.25:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1